ARCHIVES

Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change?

This article is from The Cancer Letter archive.

Vol. 32 No. 02 | January 20, 2006

Download PDF Visit The Full Archive

Related Articles

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010

NCI Criticized For Delays In Development Of New Drugs

January 24, 1975

Ohio Judge Fines CareToLive Prostate Cancer Group That Sought The Cancer Letter’s Confidential Source Material On Provenge.

February 29, 2008

John Durant Is Chosen “Cancer Fighter of the Year”.

May 17, 2002

DCE Advisors OK Concepts for Registry, Grants In Breast Cancer

June 25, 1993

Mayo Clinic’s NCI Designation Extended To Arizona, Florida Sites

July 26, 2002